Veeva Systems, the global leader in cloud software for the life sciences industry, recently announced its acquisition of Denmark-based startup Copli.

Since the acquisition earlier this summer, Copli has become Veeva Falcon MLR – an agentic medical, legal and regulatory (MLR) solution that significantly accelerates content review with the potential to eliminate 70% or more of manual MLR labor within five years, according to a press release from the company announcing the milestone.

In short, Veeva Falcon MLR aims to significantly reduce manual effort and shorten review cycles for customers in the life sciences industry.

“Our breakthrough with agentic MLR marks a fundamental shift in commercial and medical content review and approval,” said Jacob Scheel-Bech, CEO of Veeva Falcon MLR. “As part of Veeva, we can scale our vision for MLR transformation. Veeva Falcon MLR brings compliance at speed to the industry with intelligent agents that work seamlessly with Veeva PromoMats.”

Veeva Falcon MLR brings agentic automation to marketing teams, MLR groups and agencies. It executes rigorous reviews of promotional and medical materials, conducting compliance checks against approved labels and local regulations, to minimize manual effort and free reviewers for higher value work.

“The MLR process has long been a significant bottleneck in getting critical information to patients and doctors,” said Emma Hyland, vice president of Veeva Commercial Content. “With Veeva Falcon MLR, our customers can speed up the entire review cycle, automating routine labor so reviewers can become strategic advisors.”

Leaders of both organizations celebrated the new venture with announcements on LinkedIn.

"When we first met Jacob and the team, we knew two things 1. These are the people to solve the MLR problem for the industry. 2. We can go much faster together," Veeva CEO Peter Gassner wrote.

"We think the compliance aspect of MLR can be largely solved by AI and the Falcon MLR team are the people to do it," Gassner added.

Scheel-Bech shared similar sentiments, noting that he was proud of the work Copli was able to accomplish in under three years as a startup while also expressing excitement and optimism for the future ahead with Veeva.

"I'm incredibly proud of how we got here. In under three years, with no investors, we built the most advanced agentic MLR reviewer - used by the largest pharmaceutical companies across all of their major markets," Scheel-Bech wrote.

He added, "Joining forces as a start-up within Veeva gives us the reach, industry expertise, and platform to push this much further than we could alone. Thank you Peter Gassner and Emma Hyland - this is a big step to transforming Agentic MLR review for the industry."

Veeva delivers the industry cloud for life sciences with software, AI, data, and consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.

For more information, visit www.veeva.com or www.FalconMLR.veeva.com.